Neville Rodie & Shaw’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,020
| Closed | -$16K | – | 248 |
|
|
2022
Q4 | $16K | Hold |
6,020
| – | – | ﹤0.01% | 248 |
|
|
2022
Q3 | $22K | Buy |
6,020
+3,010
| +100% | +$11K | ﹤0.01% | 245 |
|
|
2022
Q2 | $10K | Hold |
3,010
| – | – | ﹤0.01% | 251 |
|
|
2022
Q1 | $13K | Hold |
3,010
| – | – | ﹤0.01% | 262 |
|
|
2021
Q4 | $29K | Hold |
3,010
| – | – | ﹤0.01% | 263 |
|
|
2021
Q3 | $51K | Hold |
3,010
| – | – | ﹤0.01% | 256 |
|
|
2021
Q2 | $84K | Hold |
3,010
| – | – | 0.01% | 258 |
|
|
2021
Q1 | $67K | Hold |
3,010
| – | – | 0.01% | 255 |
|
|
2020
Q4 | $44K | Hold |
3,010
| – | – | ﹤0.01% | 253 |
|
|
2020
Q3 | $45K | Hold |
3,010
| – | – | ﹤0.01% | 243 |
|
|
2020
Q2 | $62K | Hold |
3,010
| – | – | 0.01% | 241 |
|
|
2020
Q1 | $57K | Hold |
3,010
| – | – | 0.01% | 223 |
|
|
2019
Q4 | $87K | Hold |
3,010
| – | – | 0.01% | 244 |
|
|
2019
Q3 | $154K | Hold |
3,010
| – | – | 0.02% | 235 |
|
|
2019
Q2 | $238K | Hold |
3,010
| – | – | 0.03% | 220 |
|
|
2019
Q1 | $199K | Hold |
3,010
| – | – | 0.02% | 243 |
|
|
2018
Q4 | $167K | Hold |
3,010
| – | – | 0.02% | 227 |
|
|
2018
Q3 | $272K | Hold |
3,010
| – | – | 0.03% | 220 |
|
|
2018
Q2 | $284K | Sell |
3,010
-9,200
| -75% | -$868K | 0.03% | 213 |
|
|
2018
Q1 | $413K | Hold |
12,210
| – | – | 0.05% | 179 |
|
|
2017
Q4 | $479K | Buy |
+12,210
| New | +$479K | 0.05% | 171 |
|